Cardiometabolic effects of a novel SIRT1 activator, SRT2104, in people with type 2 diabetes mellitus
Crossref DOI link: https://doi.org/10.1136/openhrt-2017-000647
Published Online: 2017-09-02
Published Print: 2017-09
Update policy: https://doi.org/10.1136/crossmarkpolicy
Noh, Radzi M
Venkatasubramanian, Sowmya
Daga, Shruti
Langrish, Jeremy
Mills, Nicholas L
Lang, Ninian N
Hoffmann, Ethan
Waterhouse, Brian
Newby, David E
Frier, Brian M
Funding for this research was provided by:
GlaxoSmithKline
